Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day

• Huvudskapare: Maria Stella de Mello Ayres Putinatti (Författare, medförfattare), Joel Carlos Lastória (Författare, medförfattare), Carlos Roberto Padovani (Författare, medförfattare)
• Materialtyp: Bok
• Publicerad: Sociedade Brasileira de Dermatologia, 2014-04-01T00:00:00Z.
• Ämnen: article
• Länkar: Connect to this object online.

BACKGROUND: Leprosy can have its course interrupted by type 1 and 2 reactional episodes, the last named of erythema nodosum leprosum (ENL). Thalidomide has been the medication of choice for the control of ENL episodes since 1965. OBJECTIVES: These episodes can repeat and cause damages to the patient...